HCPLive
United States Conference on AIDS 2013

United States Conference on AIDS 2013 | USCA 2013

USCA is "the largest AIDS-related gathering in the US, bringing together over thousands of workers from all fronts of the HIV/AIDS epidemic—from case managers and physicians, to public health workers and advocates, people living with HIV/AIDS (PLWHAs) and policy-makers—to build national support networks, exchange the latest information and learn cutting-edge tools to address the challenges of HIV/AIDS."

Conference Coverages

Victories and Challenges in Hepatitis Testing: New USPSTF Guidelines and the Affordable Care Act
Victories and Challenges in Hepatitis Testing: New USPSTF Guidelines and the Affordable Care Act
Recently released testing guidelines and expanded access to insurance coverage under the ACA may improve awareness and treatment among HIV-positive, economically underserved, and minority populations that are disproportionately impacted by viral hepatitis infection.
Once-Daily Complera as Effective as Atripla, Though with Fewer Side Effects
Study results presented at the 2013 United States Conference on AIDS show that both combo drugs have a similar efficacy profile in ART-naïve patients, but patients treated with Complera reported fewer and less severe side effects.
Many HIV-Positive Patients Suffer Cognitive Impairments That Can Affect Treatment Outcomes
Researchers found that overall cognitive performance was below average in a sample of patients with HIV who were referred for neurocognitive evaluation. Especially affected were areas involving memory, which can have a negative effect on treatment adherence.
More Effective Treatment of HIV Patients Possible Through Pay for Performance Model
Increased spending for treatment of HIV patients does not necessarily lead to a more positive clinical outcome, according to a new study presented at the 2013 United States Conference on AIDS.
Linkage to Care Programs May Help in Reducing HIV Transmission
By providing HIV testing, counseling, screening for other STDs, transportation assistance, and other services, these programs were able to successfully identify new cases of HIV in high-risk groups and provide them with follow-up care.
Review of the Recently Revised Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
In addition to recommending antiretroviral therapy for all HIV-infected individuals to reduce the risk of disease progression, the revised document also offers guidance on initial treatment regimens, early HIV infection, drug-resistance testing, and more.
Switching to a Single-Tablet Combination of Rilpivirine/Emtricitabine/Tenofovir DF Improves Outcomes in Virologically Suppressed HIV-positive Patients
Study shows patients who switched from treatment with a ritonavir-boosted protease inhibitor maintained virologic suppression, experienced improved lipid profiles, and suffered fewer side effects.

Most Popular

$vacMongoViewPlus$ $vAR$